A recent study also shows miR-22 acts as a tumor suppressor by targeting GLUT1 and is directly correlated with the TNM stage, local relapse, distant metastasis, and survival of breast cancer patients [30]. The gene discussed is SLC2A1; the disease is neoplasm.